Tyler Cowen is a Bloomberg Opinion columnist and a professor of economics at George Mason University.

Investing.com -- TD Cowen downgraded Celsius Holdings (NASDAQ:CELH) to Hold and slashed its price target for the stock to $29 from $40 in a note Wednesday, citing slowing sales growth ...

Ten U.S. Senate Democrats provided the votes needed on Friday to advance a bill requiring authorities to detain migrants who entered the country illegally if they are suspected of theft. Ten US ...

Why are we forgetting history's lessons? We're told in school that we study history so as not to repeat its mistakes. But what if those lessons aren't sticking? Today's guest regularly invokes ...

That’s according to TD Cowen’s annual report on the near-term outlook for U.S. drug prices. This year’s report, which incorporates findings from a survey of 27 health maintenance ...

John Cowan hosts ‘Real Life’, a weekly nationwide chat show featuring a different high-profile guest every week. John talks with them about their life, their upbringing, their passions and ...

You can’t listen to them hate on you if you wouldn’t let them help you out in life.” Cowan didn’t want to point fingers on what went wrong for the second straight year. Personally ...

In a report released today, Max Rakhlenko from TD Cowen maintained a Hold rating on Tractor Supply (TSCO – Research Report), with a price target of $57.00. The company’s shares closed last ...

All looks set for a great week. ‘Let the Games Begin.’ At 74, Cowen is widely regarded as the world’s leading golf coach, boasting the most professional tournament wins by his players.

Lifetime's newest offering in its critically acclaimed "Ripped From the Headlines" series is Girl in the Garage: The Laura Cowan Story. The film tells a tale of resilience, survival, and ultimate ...

Girl in the Garage: The Laura Cowan Story is a gripping Lifetime Original Movie that tells the true story of Laura Cowan. She and her children were held captive by a family friend and endured ...

On Wednesday, Sana Biotechnology shares received an upgrade from TD Cowen analysts, shifting from a Hold to a Buy rating. The upgrade was prompted by Sana's announcement of positive interim study ...